Understand What You Need to Do to Stay Healthy Over 65

Understand What You Need to Do to Stay Healthy Over 65


Today's Boomer generation feels young at heart. They're living an active lifestyle, they have no intention of slowing down, they're booming.



from Biotech News
Share:

Why Oppenheimer Global fund is focusing on biotech as rates rise

Why Oppenheimer Global fund is focusing on biotech as rates rise


The recent volatility in the global stock market may make some investors feel queasy, but it is providing a buying opportunity in biotechnology stocks. Traders work on the floor of the New York Stock Exchange shortly after the opening bell in New York, U.S., February 13, 2018.



from Biotech News
Share:

Finanzen: Flugstornierung : Flug stornieren

Flug verpasst oder storniert? Dann haben Sie Anspruch auf Erstattung von Steuern und Gebühren – eventuell sogar auf den gesamten Ticketpreis.

from Finanztip Feed
Supported by Video Collection
Share:

Finanzen: Mahngebühren : Mahngebühren und Inkassokosten

Wer seine Rechnung zu spät überwiesen hat, soll meist noch zusätzlich Mahngebühren zahlen. Oft sind Mahnkosten allerdings zu hoch und damit unzulässig.

from Finanztip Feed
Supported by Video Collection
Share:

Wrongful-death lawsuit revisits 2011 Coronado mansion hanging death

Wrongful-death lawsuit revisits 2011 Coronado mansion hanging death


The lawsuit was filed by the mother and sister of Rebecca Zahau, who was the girlfriend of Scottsdale pharmaceuticals executive Jonah Shacknai. Six-year-old Max Shacknai, son of former Medicis Pharmaceutical Corp. CEO Jonah Shacknai, suffered brain injuries in a fall from a staircase at a Coronado mansion in 2011.



from Biotech News
Share:

Finanzen: Sonderausgaben : Sonderausgaben

Eine wichtige Kategorie der abzugsfähigen Posten in der Steuererklärung sind Sonderausgaben. Dazu zählen Sozialversicherungsbeiträge, Kirchensteuer und Spenden.

from Finanztip Feed
Supported by Video Collection
Share:

Finanzen: Strompreis : Strompreise

Strompreise können sich je nach Anbieter stark unterscheiden. Bei den Kosten pro Kilowattstunde kommt es aber auch darauf an, wo Sie wohnen.

from Finanztip Feed
Supported by Video Collection
Share:

Budget 2018 Brings Canadian Biotechnology Ecosystem Opportunity for Growth

Budget 2018 Brings Canadian Biotechnology Ecosystem Opportunity for Growth


"The industry applauds the Budget's investment to support the work of researchers at post-secondary institutions and research hospitals, the newest funding for fundamental research through the granting councils in Canadian history. The Canadian biotechnology sector is a great example of home grown talent with hundreds of early stage companies emanating from great Canadian research.



from Biotech News
Share:

Bayer: Consumer Health und Crop Science schwächeln

Bayer: Consumer Health und Crop Science schwächeln


Im Jahr 2017 hat Bayer operativ das Vorjahresniveau erreicht und ist strategisch gut vorangekommen. „Auf dem Weg zur geplanten Übernahme von Monsanto haben wir große Fortschritte gemacht“, sagte der Vorstandsvorsitzende Werner Baumann am Mittwoch auf der Bilanz-Pressekonferenz in Leverkusen. Im oper...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Finanzen: Widerruf Autokredit : Fehlerhafte Widerrufsbelehrung beim Autokredit

Weil die Widerrufsbelehrung vieler Autokredite falsch ist, können Käufer den Wagen zurückgeben. Finanztip empfiehlt diese Anwälte.

from Finanztip Feed
Supported by Video Collection
Share:

Finanzen: VW-Abgas-Skandal - Ihre Rechte als Käufer : Schadensersatzanspruch nach VW-Skandal

Vor anderthalb Jahren wurden die manipulierten Abgaswerte bei VW bekannt. Käufer von Autos mit Betrugs-Software sollten rechtliche Schritte prüfen.

from Finanztip Feed
Supported by Video Collection
Share:

'Are You Awake?' Parents Share Last Text From Their Son, Missing CDC Doctor

'Are You Awake?' Parents Share Last Text From Their Son, Missing CDC Doctor


Four times, the parents of a missing doctor with the US Centers for Disease Control and Prevention have been told that a body has been found. Each time, Tia and Terrell Cunningham are sent into heart-wrenching agony, only to learn that it isn't their son.



from Biotech News
Share:

Press release distribution, EDGAR filing, XBRL, regulatory filings

Press release distribution, EDGAR filing, XBRL, regulatory filings


FOURTH QUAR... Restructuring of Management Arrangements for Western Asset/Claymore Inflation-Linked Securities & Income Fund and Western Asset/Claymore Inflation-Linked Opportunities & Income Fund )--WIA and WIW announced changes in the funds' management arrangements designed to reduce shareholder expenses and enhance management efficiencies for the funds. As a result... )--Ensco plc today reported a loss of $0.49 per share for fourth quarter 2017 compared to earnings of $0.13 per share a year ago.



from Biotech News
Share:

Brokerages Set Fortress Biotech Inc (FBIO) Price Target at $11.00

Brokerages Set Fortress Biotech Inc (FBIO) Price Target at $11.00


Fortress Biotech Inc has been given an average rating of "Hold" by the six ratings firms that are currently covering the stock, Marketbeat Ratings reports. Two investment analysts have rated the stock with a sell rating and four have given a buy rating to the company.



from Biotech News
Share:

Doctor tied to Insys opioid kickback probe gets prison term

Doctor tied to Insys opioid kickback probe gets prison term


A Michigan doctor linked to a federal investigation into allegations that Insys Therapeutics Inc paid kickbacks to medical practitioners to prescribe its flagship opioid product was sentenced on Monday to 32 months in prison. Gavin Awerbuch, 59, was sentenced by U.S. District Judge Arthur Tarnow in Detroit after admitting that he wrote prescriptions for Insys' fentanyl-based cancer pain medication Subsys for non-legitimate uses and committed health care fraud.



from Biotech News
Share:

Probleme mit US-Übernahme überschatten Rekordgewinn von Fresenius

Probleme mit US-Übernahme überschatten Rekordgewinn von Fresenius


(dpa) Neue Probleme bei einem geplanten Zukauf in den USA trüben die Rekordergebnisse bei Fresenius. Der Gesundheitskonzern legte 2017 das 14. Jahr in Folge Höchststände bei Gewinn und Umsatz hin und verbuchte auch bei seiner Dialyse-Tochter Fresenius Medical Care (FMC) Rekordergebnisse, wie das Unt...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Finanzen: Freiwillig GKV versichert : Freiwillig gesetzlich krankenversichert

Niemand muss sich privat krankenversichern. Das gilt auch, wenn die Pflichtversicherung in der gesetzlichen Kasse endet. Wer sich freiwillig versichert, zahlt oft höhere Mindestbeiträge als Pflichtversicherte.

from Finanztip Feed
Supported by Video Collection
Share:

Kim Konradsen verlässt Takeda

Kim Konradsen verlässt Takeda


Kim Konradsen, Standortleiter von Takeda in Singen, wird das Unternehmen im Jahr 2018 nach 16 Jahren verlassen. Seine Aufgaben als Standortleiter in Singen übernimmt ab 1. April 2018 Wang Xu, aktuell Leiter des Joint-Venture Standorts Techpool von Takeda in Guangzhou, China. „Ich danke Kim Konradsen...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Rising CDC official seemed to 'evaporate' without a trace

Rising CDC official seemed to 'evaporate' without a trace


On February 12th, a Center for disease Control and Prevention employee went home sick. He hasn't been heard from since.



from Biotech News
Share:

Victory Capital Management Inc. Purchases 48,242 Shares of RTI Surgical Inc

Victory Capital Management Inc. Purchases 48,242 Shares of RTI Surgical Inc


Victory Capital Management Inc. boosted its position in RTI Surgical Inc by 23.4% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 254,576 shares of the medical equipment provider's stock after acquiring an additional 48,242 shares during the period.



from Biotech News
Share:

Research Analysts Issue Forecasts for GlaxoSmithKline plc's Q1 2018 Earnings

Research Analysts Issue Forecasts for GlaxoSmithKline plc's Q1 2018 Earnings


Equities researchers at Leerink Swann issued their Q1 2018 earnings estimates for shares of GlaxoSmithKline in a research note issued to investors on Thursday. Leerink Swann analyst S. Fernandez anticipates that the pharmaceutical company will post earnings per share of $0.69 for the quarter.



from Biotech News
Share:

Shire (SHP) Stock Rating Reaffirmed by Citigroup

Shire (SHP) Stock Rating Reaffirmed by Citigroup


's stock had its "buy" rating reiterated by equities researchers at Citigroup in a research report issued to clients and investors on Wednesday. They currently have a GBX 5,500 price target on the biopharmaceutical company's stock.



from Biotech News
Share:

Brokerages Expect ZIOPHARM Oncology Inc. (ZIOP) to Announce -$0.13 EPS

Brokerages Expect ZIOPHARM Oncology Inc. (ZIOP) to Announce -$0.13 EPS


Wall Street analysts expect ZIOPHARM Oncology Inc. to announce earnings per share for the current quarter, Zacks Investment Research reports. Three analysts have issued estimates for ZIOPHARM Oncology's earnings, with the lowest EPS estimate coming in at and the highest estimate coming in at .



from Biotech News
Share:

$10,000 reward offered in the case of missing CDC employee

$10,000 reward offered in the case of missing CDC employee


Two weeks have since Timothy Cunningham was last seen leaving his job at the Centers for Disease Control and Prevention. Now a $10,000 reward is being offered for anyone with information leading to an arrest or indictment.



from Biotech News
Share:

Comparing Fortress Biotech

Comparing Fortress Biotech


Fortress Biotech and Syros Pharmaceuticals are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, profitability, risk, valuation, analyst recommendations, institutional ownership and dividends. Fortress Biotech presently has a consensus price target of $11.00, suggesting a potential upside of 172.95%.



from Biotech News
Share:

Firefox: Im neuen Tab noch mehr besuchte Webseiten sehen

Firefox: Im neuen Tab noch mehr besuchte Webseiten sehen


Öffnet man im Firefox-Browser einen neuen Tab, werden standardmäßig sechs Schnellwahl-Kacheln mit den am häufigsten besuchten Webseiten angezeigt. Dieses sehr nützliche Feature kennen die Nutzer des Opera-Browsers schon seit Jahren. Wer beim Firefox mehr als sechs Schnellwahl-Kacheln benötigt, kann diese sehr einfach verdoppeln. Mit einem kleinen Trick lassen sich aber auch viel mehr Kachel im neuen Tab anzeigen.

Schnellwahl-Kacheln verdoppeln

Die einfachste Vermehrung der Schnellwahl-Icons führt über das Zahnrad-Symbol im neuen Tab. Im Bereich Meistbesuchte Seiten aktivierst du die Option Zwei Reihen anzeigen. Da die Änderungen sofort greifen, ist kein Neustart des Browsers erforderlich.

Mehr als 12 Schnellwahl-Kacheln anzeigen

Wer mit 12 Schnellwahlen nicht auskommt, der kann über about:config beliebig viele Schnellwahlkacheln der Startseite hinzufügen.

Gib den Befehl about:config in die Adresszeile des Firefox ein und drücke die Taste [Enter]. Die nachfolgende Warnmeldung bestätigst du mit dem Button Ich bin mir der Gefahren bewusst!

Suche dann nach dem Eintrag browser.newtabpage.activity-stream.topSitesCount und öffne ihn mit einem Doppelklick. Im Eingabefeld tippst du dann die erforderliche Anzahl ein und bestätigst du mit OK.

Abschließend startest du den Browser neu, damit die Änderungen vom Firefox übernommen werden. Ab sofort steht dir die gewünschten Schnellwahl-Icons zur Verfügung.

Tipp:

Alle Elemente können auch bearbeitet werden, wenn man mit dem Mauszeiger über die Kachel fährt und auf das Drei-Punkte-Icon klickt. Die Webseite kann hier beispielsweise angepinnt oder gelöst und die URL bearbeitet werden.

Für nicht so häufig besuchte, aber dennoch wichtige Webseiten empfehlen wir auf jeden Fall das Anpinnen, damit sie nicht irgendwann aussortiert wird. Eine Sortierungsfunktion per Drag and Drop ist noch nicht vorhanden, sie soll voraussichtlich ab Firefox-Version 59 verfügbar sein.



Supported by World News Digest
Share:

AmerisourceBergen Corp. (ABC) Shares Sold by Sei Investments Co.

AmerisourceBergen Corp. (ABC) Shares Sold by Sei Investments Co.


Sei Investments Co. reduced its stake in shares of AmerisourceBergen Corp. by 4.7% during the 4th quarter, Holdings Channel reports.



from Biotech News
Share:

Concerns over CDC response to E. coli outbreak

Concerns over CDC response to E. coli outbreak


A row of Romaine lettuce and leaf lettuces in adjacent rows. An E.coli outbreak thought to have stemmed from Romaine recently hospitalized at least 26 people in the U.S. and Canada - including two in Connecticut.



from Biotech News
Share:

Critical Contrast: Ironwood Pharmaceuticals

Critical Contrast: Ironwood Pharmaceuticals


Ironwood Pharmaceuticals and Infinity Pharmaceuticals are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their valuation, risk, dividends, analyst recommendations, profitability, institutional ownership and earnings. Infinity Pharmaceuticals has lower revenue, but higher earnings than Ironwood Pharmaceuticals.



from Biotech News
Share:

Doctors get rich from controversial drug maker as patients become addicts

Doctors get rich from controversial drug maker as patients become addicts


Tamisan Witherspoon lost her marriage, her home and her health while two Alabama pain doctors amassed a fortune at her expense. The suburban soccer mom turned couch-potato addict - who overdosed weekly from opioids - blames Drs.



from Biotech News
Share:

Raymond James Financial Services Advisors Inc. Has $5.95 Million Holdings in AstraZeneca plc

Raymond James Financial Services Advisors Inc. Has $5.95 Million Holdings in AstraZeneca plc


Raymond James Financial Services Advisors Inc. raised its position in shares of AstraZeneca plc by 50.7% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission . The institutional investor owned 171,382 shares of the company's stock after purchasing an additional 57,669 shares during the quarter.



from Biotech News
Share:

Windows 10: Screenshots ohne Snipping Tool oder der Taste „Druck“ erstellen

Windows 10: Screenshots ohne Snipping Tool oder der Taste „Druck“ erstellen


Fotos vom Bildschirminhalt sind ein beliebtes Mittel um die unterschiedlichsten Dinge zu dokumentieren. Die einfachste Möglichkeit ist das Drücken der Taste [Druck] um den Bildschirminhalt in die Zwischenablage zu kopieren. Von hier aus muss das Bildschirmfoto dann nur noch in Word oder eine E-Mail übertragen werden. Eine andere Variante erlaubt aber auch die automatische Speicherung als PNG-Datei.

XBox-App als Screenshot-Tool

Windows 10 enthält von Haus aus die XBox-App in der eine Spielleiste  mit Aufzeichnungsfunktion integriert ist.  Grundsätzlich ist sie zwar zur Aufnahme in Computergames vorgesehen, kann aber auch innerhalb anderer Programme zur Bild- oder Videoaufnahme verwendet werden. Letzteres funktioniert nur, wenn dein Computer die geforderten Video-Hardware-Voraussetzungen erfüllt.

Starten der Spielleiste

Über die Tastenkombination [Windows][G] rufst du die Spielleiste auf, die sich beim ersten Mal mit der Frage Möchten Sie die Spielleiste öffnen? meldet. Bestätige die Meldung mit Ja, das ist ein Spiel.

Nun klickst du auf das Kamera-Symbol um den Screenshot zu erstellen. Das Bild wird automatisch im PNG-Format gespeichert. Alle Aufnahmen findest du dann in der Bibliothek unter Videos | Aufzeichnungen.

Ausnahmen

Die Screenshot-Funktion über die Spielleiste funktioniert nur innerhalb anderer Apps. Im Windows Explorer oder auf dem Desktop können auf diese Weise keine Aufnahmen angefertigt werden. Dafür empfehlen wir das Snipping Tool, das ebenfalls zu den Bordmitteln von Windows gehört.



Supported by World News Digest
Share:

Eli Lilly and Co (LLY) Expected to Announce Quarterly Sales of $5.47 Billion

Eli Lilly and Co (LLY) Expected to Announce Quarterly Sales of $5.47 Billion


Wall Street analysts predict that Eli Lilly and Co will announce $5.47 billion in sales for the current fiscal quarter, Zacks reports. Three analysts have made estimates for Eli Lilly and's earnings, with the lowest sales estimate coming in at $5.42 billion and the highest estimate coming in at $5.53 billion.



from Biotech News
Share:

FDA approves blood test that can detect concussions Source: Cox Media Group

FDA approves blood test that can detect concussions Source: Cox Media Group


The Food and Drug Administration on Wednesday approved a breakthrough blood test that can help detect concussions in adults . The blood test, also known as the Banyan Brain Trauma Indicator Test , works by measuring UCH-L1 and GFAP, both proteins released from the brain into the blood, within 12 hours of a head injury.



from Biotech News
Share:

DA exec, officials visit Central Luzon biotech farm

DA exec, officials visit Central Luzon biotech farm


The Department of Agriculture Biotechnology Program Office in partnership with the San Manuel Tarlac Farmers Multi-Purpose Cooperative welcomed First District Ilocos Sur Congressman Deogracias Victor B. Savellano and Leyte Third District Congressman Vicente S.E. Veloso together with committee secretaries and legislative staff for the Biotechnology Corn Farm visit in San Manuel, Tarlac, recently. Undersecretary for Policy and Planning, Project Development, Research and Development and Regulations, Chair of DA Biotech Program Steering Committee Segfredo R. Serrano assured that the genetically modified corn is safe.



from Biotech News
Share:

Drug That Promises to Kill Flu in a Day Approved in Japan

Drug That Promises to Kill Flu in a Day Approved in Japan


Japan has approved a drug that its maker says can kill the flu virus in 24 hours, advancing what health experts believe could be a breakthrough in the way the illness is treated. Friday's fast-tracked approval from Japan's health ministry means Shionogi & Co.



from Biotech News
Share:

CDC seeking $400 million to replace lab for deadliest germs

CDC seeking $400 million to replace lab for deadliest germs


Thirteen years after building a state-of-the-art lab for the world's most dangerous germs, the nation's top public health agency is asking for more than $400 million to build a new one. Officials at the Centers for Disease Control and Prevention say the current lab building in Atlanta is quickly wearing down, and cannot be upgraded without shutting down the facility for years.



from Biotech News
Share:

Flu kills 13 more children, bringing the toll this season to 97 kids

Flu kills 13 more children, bringing the toll this season to 97 kids


The flu vaccine may only be 36% effective, but it could significantly decrease your chance of a heart attack. Tony Spitz has the details.



from Biotech News
Share:

Barclays Cuts United Therapeutics (UTHR) Price Target to $105.00

Barclays Cuts United Therapeutics (UTHR) Price Target to $105.00


The brokerage currently has an "underweight" rating on the biotechnology company's stock. Barclays' price target would suggest a potential downside of 14.05% from the stock's previous close.



from Biotech News
Share:

Why small biotech stocks are the best choice for big returns

Why small biotech stocks are the best choice for big returns


Each week, a professional investor tells us where he'd put his money. This week: Carl Harald Janson of the International Biotechnology Trust selects three potential acquisition targets in the biotechnology sector.



from Biotech News
Share:

Sangamo in $3 billion gene-editing deal with Gilead

Sangamo in $3 billion gene-editing deal with Gilead


U.S. drugmaker Gilead Sciences Inc will use Sangamo Therapeutics Inc's gene-editing technology to develop cancer treatments in a deal potentially worth about $3 billion to Sangamo, the companies said on Thursday. The deal is the latest by a major drugmaker looking to develop lucrative gene therapies that have the potential to treat ailments by directly targeting disease-causing genes.



from Biotech News
Share:

Missing CDC employee left work sick 10 days ago, hasna t been seen since, police say

Missing CDC employee left work sick 10 days ago, hasna t been seen since, police say


Police are asking the public for help finding a missing Centers for Disease Control and Prevention employee who went home sick 10 days ago and hasn't been seen or heard from since. Timothy Cunningham, 35, went to work on Feb. 12 and left sick, the Atlanta Police Department said.



from Biotech News
Share:

Finanzen: Kabel- und DSL-Vergleich : Kabel- und DSL-Vergleich

Mit einem älteren Internet- und Telefontarif zahlen Sie wahrscheinlich zu viel. So wechseln Sie ohne Unterbrechung zu einem günstigeren Internetanbieter.

from Finanztip Feed
Supported by Video Collection
Share:

Missing CDC employee left work sick 10 days ago, hasn't been seen since, police say

Missing CDC employee left work sick 10 days ago, hasn't been seen since, police say


Police are asking the public for help finding a missing Centers for Disease Control and Prevention employee who went home sick 10 days ago and hasn't been seen or heard from since. Timothy Cunningham, 35, went to work on Feb. 12 and left sick, the Atlanta Police Department said.



from Biotech News
Share:

Finanzen: Stromzähler : Stromzähler

Verbraucher bekommen in den nächsten Jahren digitale Stromzähler oder intelligente Messsysteme installiert. Das schreibt das Messstellenbetriebsgesetz vor. Für Haushalte bedeutet das höhere Kosten von bis zu 100 Euro pro Jahr.

from Finanztip Feed
Supported by Video Collection
Share:

Treatment Debates Won't Slow Down Biotechs

Treatment Debates Won't Slow Down Biotechs


A number of biotech companies, including Gilead Sciences , have staked a lot on CAR-T therapies for cancer patients. Today, Guggenheim's Tony Butler and his team take a look at the debate about one set of side effects for these treatments, but ultimately they don't think they'll slow the adoption of these options.



from Biotech News
Share:

RPT-INSIGHT-Seed firms scramble to stop a 'cancer' in Canada's cash crop

RPT-INSIGHT-Seed firms scramble to stop a 'cancer' in Canada's cash crop


Inside a laboratory in Winnipeg, Manitoba, a Monsanto Co research technician uses tweezers to transfer pollen from one canola plant to another, a small step toward creating a new breed of the vegetable oil-producing crop. It's an early stage of a high-stakes effort to control the biggest threat to Canada's C$27-billion canola industry - a crop disease called clubroot that presents unique challenges for Monsanto, along with rival seed developers DowDuPont and Bayer AG.



from Biotech News
Share:

RTI Surgical (RTIX) Set to Announce Earnings on Thursday

RTI Surgical (RTIX) Set to Announce Earnings on Thursday


RTI Surgical is scheduled to be posting its quarterly earnings results before the market opens on Thursday, March 1st. Analysts expect RTI Surgical to post earnings of $0.03 per share for the quarter.



from Biotech News
Share:

Press release distribution, EDGAR filing, XBRL, regulatory filings

Press release distribution, EDGAR filing, XBRL, regulatory filings


Revenue increased 3.1% fo... )--Life Storage, a leading national self storage facility owner and operator, reported operating results for 2017 and its outlook for 2018.



from Biotech News
Share:

Here's Our New Best Stocks to Buy List

Here's Our New Best Stocks to Buy List


Our latest list of best stocks to buy now gives you five companies with rock-solid balance sheets and that are riding strong trends that can't be disrupted by Wall Street jitters. We love these stocks, because any market downturn - like the 10% drop we just saw - will be just a small blip in these stocks' overall performance.



from Biotech News
Share:

Finanzen: Billiggas : Billiggas

Billiggas-Tarife sind oft ein Lockangebot der Gasversorger, um Kunden langfristig an sich zu binden. Sie sind für die Anbieter nicht kostendeckend, hat eine Studie vom Verbraucher-Ratgeber Finanztip ergeben. Nach dem ersten Vertragsjahr drohen aber deutlich höhere Kosten für vermeintlich günstiges Gas. Wir sagen, wo.

from Finanztip Feed
Supported by Video Collection
Share:

Medigene nimmt erste Hürde auf dem Weg zu neuer Krebsimmuntherapie

Medigene nimmt erste Hürde auf dem Weg zu neuer Krebsimmuntherapie


(dpa-AFX) Das Management des Biotechnologieunternehmens Medigene kann voraussichtlich bald mit den Forschungen zu seinem wichtigsten Hoffnungsträger, einer neuartigen Krebsimmuntherapie, beginnen. Das Unternehmen bekam die Zustimmung von der zuständigen Behörde Paul-Ehrlich Institut für das Design e...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Ligand reports 4Q loss

Ligand reports 4Q loss


The San Diego-based company said it had a loss of 33 cents per share. Earnings, adjusted for one-time gains and costs, were $1.31 per share.



from Biotech News
Share:

Merck investiert weitere 40 Mio. € in den Ausbau von Produktion und Distribution in Asien

Merck investiert weitere 40 Mio. € in den Ausbau von Produktion und Distribution in Asien


Merck hat bekannt gegeben, innerhalb von zwei Jahren weitere 40 Mio. € in den Aufbau einer tragfähigen Herstellungs- und Distributionsplattform in Asien zu investieren. Bereits im November 2016 hatte das Unternehmen die Investition von 80 Mio. € im Bereich Life Science an seinem chinesischen Standor...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

UPDATE 2-Merck to buy virus-based cancer drug firm Viralytics for $394 mln

UPDATE 2-Merck to buy virus-based cancer drug firm Viralytics for $394 mln


The idea is to cause cancer cells to rupture and die, while also stimulating a wider immune system response in the body. The deal, which is conditional on no better offer emerging from a counter-bidder, represents a premium of 160 percent to the average stock price over the past month - another example of the outsized offers often needed to clinch biotech takeovers.



from Biotech News
Share:

Doctors get rich from controversial drug maker as patients become addicts

Doctors get rich from controversial drug maker as patients become addicts


Tamisan Witherspoon lost her marriage, her home and her health while two Alabama pain doctors amassed a fortune at her expense. The suburban soccer mom turned couch-potato addict - who overdosed weekly from opioids - blames Drs.



from Biotech News
Share:

Stark Wipes Out $2.5 Billion Verdict in Hep C Drug Patent Case

Stark Wipes Out $2.5 Billion Verdict in Hep C Drug Patent Case


A Delaware federal judge on Feb. 16 overturned a massive $2.5 billion jury verdict against Gilead Sciences Inc., finding that a patent held by a unit of Merck & Co. Inc. was too broad to be valid.



from Biotech News
Share:

Finanzen: Sonderkündigungsrecht Strom : Sonderkündigungsrecht Strom und Gas

Wenn eine Preiserhöhung für Strom oder Gas ins Haus flattert, haben Sie ein Sonderkündigungsrecht. Sie können den Liefervertrag kündigen, ohne eine Frist beachten zu müssen.

from Finanztip Feed
Supported by Video Collection
Share:

OraSure Technologies, Inc. (OSUR) EVP Brian Smith Sells 20,000 Shares

OraSure Technologies, Inc. (OSUR) EVP Brian Smith Sells 20,000 Shares


OraSure Technologies, Inc. EVP Brian Smith sold 20,000 shares of the firm's stock in a transaction on Friday, February 16th. The shares were sold at an average price of $17.97, for a total transaction of $359,400.00.



from Biotech News
Share:

Finanzen: Kappungsgrenze : Kappungsgrenze bei Mieterhöhungen

Nicht jede Mieterhöhung ist zulässig. Mieter können sich oft gegen zu viel Miete zur Wehr setzen. Denn viele Vermieter missachten die Kappungsgrenze und verlangen überhöhte Beträge.

from Finanztip Feed
Supported by Video Collection
Share:

Finanzen: Handwerkerkosten : Handwerkerleistungen

Wenn Handwerker in Ihrer Wohnung arbeiten, kann das eine Steuererleichterung bis zu 1.200 Euro im Jahr bringen. Abzugsfähig sind die überwiesenen Arbeits- und Fahrtkosten.

from Finanztip Feed
Supported by Video Collection
Share:

Seattle Genetics Acquires Cascadian Therapeutics, Continuing a Strong ...

Seattle Genetics Acquires Cascadian Therapeutics, Continuing a Strong ...


On January 31, two Seattle biotech companies, Seattle Genetics and Cascadian Therapeutics, announced a merger agreement under which Seattle Genetics will acquire Cascadian Therapeutics for $614 million. [1] The announcement catapulted Cascadian Therapeutics shares to a 16-month high, and a 69% increase over the previous day's closing price.



from Biotech News
Share:

Shareholder Alert: Levi & Korsinsky, LLP Notifies Shareholders of...

Shareholder Alert: Levi & Korsinsky, LLP Notifies Shareholders of...


SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Johnson & Johnson of a Class Action Lawsuit and a Lead Plaintiff Deadline of April 9, 2018 - JNJ that a securities class action lawsuit has been commenced in the United States District Court for the District of New Jersey. To get more information go to: or contact Joseph E. Levi, Esq.



from Biotech News
Share:

Domestic violence 'code of silence' contributes to prevalence across races, classes

Domestic violence 'code of silence' contributes to prevalence across races, classes


Her daughter called screaming that her boyfriend was "busting her head against the bathtub," said Marlow. "'Mom, he's going to kill me!'" And then, the phone went dead."



from Biotech News
Share:

Kentucky accuses Cardinal Health of contributing to opioid epidemic

Kentucky accuses Cardinal Health of contributing to opioid epidemic


A pharmacist holds prescription painkiller OxyContin, 40mg pills, made by Purdue Pharma L.D. at a local pharmacy, in Provo, Utah, U.S., April 25, 2017. REUTERS/George Frey Kentucky's attorney general on Monday accused the drug distributor Cardinal Health Inc of contributing to the opioid epidemic by failing to halt or report suspiciously large or frequent orders by pharmacies of prescription painkillers.



from Biotech News
Share:

After terrorizing the Inland Empire, polio was finally defeated

After terrorizing the Inland Empire, polio was finally defeated


A special cylinder called an iron lung arrived at the San Bernardino County Hospital on Aug. 22, 1956, flown in from Oregon to help 10-month-old polio patient Rebecca Fuller of Hinkley continue to breathe. A year earlier, Janet Holden, 19, of Pomona was a candidate for queen of the Los Angeles County Fair when she suddenly collapsed while posing for photos.



from Biotech News
Share:

How biotech firm Illumina smooths out buying for online customers

How biotech firm Illumina smooths out buying for online customers


The manufacturer of products and systems used in biological research deployed a new e-commerce site that has resulted in customers buying more, and more frequently. There's not much that's simple about the products biotech company Illumina Inc. develops and manufactures, nor about how they're used.



from Biotech News
Share:

Flu Shot During Pregnancy Poses No Harm to Baby

Flu Shot During Pregnancy Poses No Harm to Baby


There's some good news for expecting moms who are trying to weather a brutal flu season -- a new study shows that getting the flu vaccine during pregnancy causes no harm to newborns. Researchers reviewed records on more than 400,000 infants born between 2004 and 2014, and found no increased risk of infant hospitalization or death following maternal inoculation during pregnancy with either the flu vaccine or Tdap vaccine.



from Biotech News
Share:

How Amazon Could Lose Its Healthcare Bid While Drug Distributor Stocks Win

How Amazon Could Lose Its Healthcare Bid While Drug Distributor Stocks Win


Amazon.com has been one of the most innovative and disruptive companies of this century, with incredible success in areas that lie outside of what has been historically perceived as its core business . Thus, every announcement or speculation that Amazon will enter into a particular industry sends stocks of that industry into a tailspin.



from Biotech News
Share:

Android: Google-App bekommt bald Screenshot-Bearbeitung spendiert

Android: Google-App bekommt bald Screenshot-Bearbeitung spendiert


Geräte unabhängig ist die Erstellung von Screenshots auf dem Handy schon seit mehreren Jahren möglich. Mit den Tasten Leise und Power kann man ein Bildschirmfoto machen, dass anschließend in der Galerie gespeichert wird. Bald soll es in der Google-App eine zusätzliche Funktion geben, die eine direkte Bearbeitung ermöglichen soll.

Der Screenshot-Editor wird derzeit nur in der aktuellen Betaversion der Google-App getestet und ist noch nicht für alle Android-Nutzer verfügbar.

Wenn man bis jetzt einen Screenshot bearbeiten wollte, musste man zu Bildbearbeitungs-Apps anderer Hersteller greifen. Je nach Ausstattung dieser Editor-Apps ist dann auch ein direktes Teilen mit anderen Personen möglich.

Betaversion herunterladen

Um den Editor zu testen, musst du dich für das Beta-Programm registrieren und bekommst danach die Google-Testversion per Update zur Verfügung gestellt. Den Einladungslink findest du hier.

Nach dem Download der Google-Beta-Version rufst du in den Google Einstellungen den Bereich Konten & Datenschutz auf und aktivierst den Eintrag Screenshots bearbeiten und teilen über den rechten Schalter.

Beschneiden und Beschriften

In der Testversion wird im Augenblick nur die Beschneidung und eine Beschriftung von Screenshots angeboten. Das Teilen erfolgt dann über das Google-Sharing-Menü. Außerdem funktioniert dieses Feature nur in der Google-Suche. Systemübergreifend wird es wohl erst mit der offiziellen Version möglich sein.

iPhone-Besitzer haben es mit der Screenshot-Bearbeitung wesentlich leichter. Seit iOS11 ist die direkte Bearbeitung sowie das Teilen im Betriebssystem bereits eingebaut.



Supported by World News Digest
Share:

Myriad's EndoPredict offers better prediction of breast cancer recurrence, analysis shows

Myriad's EndoPredict offers better prediction of breast cancer recurrence, analysis shows


Large National Payer Expands Coverage Policy to Include EndoPredict for Guiding Extended Hormone Therapy for Patients with ER+ Breast Cancer Myriad Genetics, Inc. today announced that a comparative analysis of commercially available prognostic breast cancer tests in patients with early-stage breast cancer has been published in JAMA Oncology . A key finding is that Myriad's EndoPredict significantly outperformed Oncotype DX Recurrence Score at predicting the risk of disease recurrence in patients with early-stage breast cancer.



from Biotech News
Share:

Susquehanna Bancshares Analysts Give Dr Pepper Snapple Group (DPS) a $129.00 Price Target

Susquehanna Bancshares Analysts Give Dr Pepper Snapple Group (DPS) a $129.00 Price Target


The firm presently has a "hold" rating on the stock. Susquehanna Bancshares' price target suggests a potential upside of 12.06% from the stock's previous close.



from Biotech News
Share:

Police searching for missing CDC employee

Police searching for missing CDC employee


Nearly a week has passed since Timothy Cunningham was last seen leaving his job at the Centers for Disease Control and Prevention.



from Biotech News
Share:

Finanzen: Sonderkündigungsrecht Strom : Sonderkündigungsrecht Strom

Wenn eine Strompreiserhöhung ins Haus flattert, haben Sie ein Sonderkündigungsrecht. Sie können den Liefervertrag kündigen, ohne eine Frist beachten zu müssen.

from Finanztip Feed
Supported by Video Collection
Share:

Kurz notiert: Beim Netto Marken-Discount jetzt noch schneller Bargeld abheben

Kurz notiert: Beim Netto Marken-Discount jetzt noch schneller Bargeld abheben


In einigen Supermärkten können die Kunden bei Kartenzahlung sich auch direkt Bargeld auszahlen lassen. Besonders vorteilhaft ist diese Möglichkeit, wenn keine passende Bankfiliale in der Nähe ist.

Die Bargeldauszahlung ist bis 200 Euro möglich und ist gebührenfrei. Bisher ist in allen teilnehmenden Geschäften aber ein Mindestumsatz von 20 Euro erforderlich um das Geld abheben zu können. Beim Netto Marken-Discount ist dieser Mindest-Einkaufswert heruntergesetzt worden. Ab sofort bekommt man schon ab einem Umsatz von 10 Euro die Gelegenheit, sich Bargeld auszahlen zu lassen.



Supported by World News Digest
Share:

Finanzen: Zeitmietvertrag : Zeitmietvertrag

Vorsicht bei Zeitmietverträgen. Für Mieter sind befristete Mietverträge in der Regel von Nachteil: Sie binden sich langfristig und verzichten auf Kündigungsschutz. Aber nicht alle Befristungen sind wirksam. Dazu brauchen Vermieter nämlich einen Grund, den sie konkret schriftlich mitteilen müssen.

from Finanztip Feed
Supported by Video Collection
Share:

Finanzen: Dienstfahrrad : Dienstfahrrad versteuern

Ein Dienstfahrrad, das auch privat genutzt wird, ist vom Arbeitnehmer ähnlich zu versteuern wie ein Dienstauto. Ein Rad über den Arbeitgeber zu leasen lohnt sich in vielen Fällen.

from Finanztip Feed
Supported by Video Collection
Share:

MediciNova Announces Upcoming Presentation of the SPRINT-MS Phase 2b...

MediciNova Announces Upcoming Presentation of the SPRINT-MS Phase 2b...


MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market and the JASDAQ Market of the Tokyo Stock Exchange , today announced that an abstract regarding the completed SPRINT-MS Phase 2b Trial of MN-166 in progressive multiple sclerosis , which was conducted through the National Institutes of Health -sponsored NeuroNEXT network, has been selected for plenary presentation at the American Academy of Neurology 70th Annual Meeting to be held April 21-27, 2018 in Los Angeles, California. The presentation entitled "A Phase II Trial of Ibudilast in Progressive Multiple Sclerosis" will be presented by Dr. Robert Fox, Staff Neurologist at the Cleveland Clinic and the principal investigator of this clinical trial.



from Biotech News
Share:

Finanzen: Bitcoin : Bitcoin

Der Kurs der digitalen Währung Bitcoin ist Anfang 2018 stark eingebrochen. Die Blockchain-Technologie macht die Kryptowährung vor Manipulation sicher. Zur langfristigen Geldanlage taugen Bitcoins nicht.

from Finanztip Feed
Supported by Video Collection
Share:

Fighting the flu? This technology tries to help you get well faster

Fighting the flu? This technology tries to help you get well faster


As one of the worst influenza outbreaks on record sweeps across America, that's a question hundreds of scientists, inventors, and health officials are working hard to answer. For a start, flu experts recommend getting a vaccine, which reduces the chance of getting the flu by about one-third, though it's just 25% effective against the worst strain, according to the Centers for Disease Control and Prevention .



from Biotech News
Share:

Den Darkmode im Edge Mobile Browser aktivieren

Den Darkmode im Edge Mobile Browser aktivieren


Etliche Webbrowser bieten neben der Desktopversion auch in der mobilen Version für Handys und Tablets, ein dunkles Design an. Diesen Darkmode finde ich persönlich gerade für die Mobilgeräte sehr vorteilhaft. Der Kontrast ist sehr viel besser und alle Elemente sind gut sichtbar. Auch der seit kurzem in Deutschland erhältliche, mobile Edge Browser von Microsoft besitzt eine „dunkle Seite“.

Um zu dieser dunklen Seite von Edge zu wechseln, musst du die Funktion in den Einstellungen aktivieren.

Öffne den Browser und tippe unten rechts auf das Icon mit den drei Punkten und navigiere dann zu Einstellungen | Darstellungen | Design. Hier findest du drei Auswahlmöglichkeiten:

  1. Standard
  2. Hell
  3. Dunkel

Wenn du auf den Eintrag Dunkel tippst, dann wird das Design sofort und ohne Browser-Neustart aktiviert.



Supported by World News Digest
Share:

Shire (SHP) PT Lowered to GBX 4,000 at Credit Suisse Group

Shire (SHP) PT Lowered to GBX 4,000 at Credit Suisse Group


The firm presently has an "outperform" rating on the biopharmaceutical company's stock. Credit Suisse Group's price target would suggest a potential upside of 24.92% from the company's previous close.



from Biotech News
Share:

Aptose Biosciences (APTO) vs. Arena Pharmaceuticals (ARNA) Head to Head Contrast

Aptose Biosciences (APTO) vs. Arena Pharmaceuticals (ARNA) Head to Head Contrast


Aptose Biosciences and Arena Pharmaceuticals are both small-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, dividends, risk, profitability, institutional ownership, valuation and analyst recommendations. This is a breakdown of recent ratings and target prices for Aptose Biosciences and Arena Pharmaceuticals, as provided by MarketBeat.com.



from Biotech News
Share:

Head-To-Head Analysis: Simply Good Foods

Head-To-Head Analysis: Simply Good Foods


Nutraceutical Int'l and Simply Good Foods are both small-cap non-cyclical consumer goods & services companies, but which is the superior business? We will compare the two companies based on the strength of their risk, valuation, analyst recommendations, dividends, earnings, institutional ownership and profitability. Nutraceutical Int'l has higher earnings, but lower revenue than Simply Good Foods.



from Biotech News
Share:

Paratek Pharmaceuticals (PRTK) Stock Rating Upgraded by Zacks Investment Research

Paratek Pharmaceuticals (PRTK) Stock Rating Upgraded by Zacks Investment Research


The firm currently has a $16.00 target price on the specialty pharmaceutical company's stock. Zacks Investment Research 's target price points to a potential upside of 14.49% from the stock's current price.



from Biotech News
Share:

Gilead wins reversal of $2.54 billion hepatitis C drug patent verdict

Gilead wins reversal of $2.54 billion hepatitis C drug patent verdict


A federal judge in Delaware has overturned a jury's verdict requiring Gilead Sciences Inc to pay a record $2.54 billion because its hepatitis C drugs Sovaldi and Harvoni infringed a patent held by rival Merck & Co Inc. The verdict had been the largest ever in a U.S. patent case but U.S. District Judge Leonard Stark in Wilmington, Delaware, on Friday ruled Merck's patent was invalid. He said it did not meet a requirement that it disclose how to make and use the treatment it covered without undue experimentation.



from Biotech News
Share:

Finanzen: Elektroheizung : Elektroheizung - Heizen mit Strom

Mehr als zwei Millionen Haushalte heizen mit Strom. Ein günstiger Wärmestromtarif ist leicht gefunden und abgeschlossen.

from Finanztip Feed
Supported by Video Collection
Share:

Finanzen: Wärmepumpen : Wärmepumpe

Für elektrische Wärmepumpen gibt es spezielle Stromtarife. Sie sind rund 30 Prozent günstiger als Haushaltsstrom.

from Finanztip Feed
Supported by Video Collection
Share:

Finanzen: Nachtspeicherheizung : Nachtspeicherheizung

Mit günstigem Nachtstrom lässt sich viel Geld sparen.

from Finanztip Feed
Supported by Video Collection
Share:

Finanzen: Allnet-Flat : Allnet-Flat-Vergleich

Handytarife, die alles abdecken, gibt es schon für 10 Euro im Monat – inklusive schnellem Internet über LTE. Ein Angebots-Check.

from Finanztip Feed
Supported by Video Collection
Share:

Finanzen: Ratgeber Tagesgeld : Tagesgeldvergleich

Verlassen Sie sich nicht auf Zinstabellen: Wir sagen Ihnen, wo Ihr Tagesgeld am meisten abwirft und sicher angelegt ist.

from Finanztip Feed
Supported by Video Collection
Share:

Finanzen: Solarthermie : Solarthermie

Mit einer Solarthermie-Anlage können Sie Ihre Energiekosten verringern und profitieren von staatlichen Förderungen. Wie Sie am günstigsten zu Ihrer eigenen Solaranlage kommen.

from Finanztip Feed
Supported by Video Collection
Share:

Georgia school to drug-test students by using hair samples

Georgia school to drug-test students by using hair samples


The Columbus Ledger-Enquirer reports that Brookstone School in Columbus recently announced that the drug-testing of students in grades 8-12 will be voluntary next school year - and then mandatory in succeeding years. The newspaper reports that Brookstone plans to use students' hair samples which are sent to Psychemedics Corp. to conduct the testing.



from Biotech News
Share:

Android: Neues Update verbessert die Bedienung der Telefon-App

Android: Neues Update verbessert die Bedienung der Telefon-App


Seit kurzem verteilt Google ein Update für die Android-Telefon-App, die den Bedienungskomfort wesentlich verbessert.

Wer während eines Telefonats auf dem Handy eine andere Tätigkeit durchführen möchte, minimiert die Telefon-App, die anschließend im Hintergrund über die Benachrichtigungsleiste weiterläuft. Von dort lässt sie sich mit ein paar Klicks wieder in den Vordergrund zurückholen.

Ansprechendes Bubble-Design

Dieses Minimierungsfeature wurde nun verbessert. Ab sofort erscheint ein kleines, rundes Kontaktbild (falls Foto hinterlegt) deines Gesprächspartners auf dem Display. Dieses Bubble lässt sich in alle Richtungen frei verschieben und verbleibt immer im Vordergrund.

Ein Fingertipp auf das Bubble-Icon öffnet ein Kontextmenü, in dem du das Mikrofon stumm schalten, zum Telefonat zurückkehren oder das Gespräch beenden kannst. Auch der Lautsprecher lässt sich hier natürlich einschalten.

Das Update befindet sich derzeit noch im Roll-out und ist noch nicht auf allen Geräten angekommen.



Supported by World News Digest
Share:

A Foolish Take: How the US market plunge rippled across the globe

A Foolish Take: How the US market plunge rippled across the globe


The Dow Jones Industrials have taken a big hit over the past two weeks, including two declines in the past five trading sessions of 1,000 points or more. Even after a bounce on Feb. 9, the Dow had fallen more than 2,400 points, and its close on Feb. 8 represented more than a 10% drop, meeting the definition of a correction for the average.



from Biotech News
Share:

Biogen (BIIB) Downgraded to "Hold" at BidaskClub

Biogen (BIIB) Downgraded to "Hold" at BidaskClub


Other equities analysts have also issued reports about the company. Guggenheim initiated coverage on Biogen in a report on Monday, October 23rd.



from Biotech News
Share:

Press release distribution, EDGAR filing, XBRL, regulatory filings

Press release distribution, EDGAR filing, XBRL, regulatory filings


To celebrate, PetSmart is having a grand opening e... )--While the nation celebrates Random Acts of Kindness Day this weekend, Kirby, the charming hero known for his powerful Copy Abilities, is preparing a celebration of ... )--Second Sight Medical Products, Inc. , a developer, manufacturer and marketer of implantable visual prosthetics that ... )--Elliott Advisors Limited , which advises funds that collectively hold an economic interest in NXP Semiconductors N.V. --The "China: Soda Ash - Market Report - Analysis And Forecast To 2025" report has been added to ResearchAndMarkets.com's offering.



from Biotech News
Share:

Stocks stretch winning streak to 6 days despite turbulence

Stocks stretch winning streak to 6 days despite turbulence


Stocks closed out their strongest week in five years Friday and have now recovered more than half of the losses they suffered in a plunge at the beginning of the month.



from Biotech News
Share:

22 more children die from flu, brings total to 84

22 more children die from flu, brings total to 84


Southern states have been especially hard hit, with 24 of the pediatric deaths taking place from Mississippi to North Carolina. ATLANTA Another 22 children have died from the flu in the United States, the Centers for Disease Control and Prevention reported Friday.



from Biotech News
Share:

Flu season shows signs of leveling off

Flu season shows signs of leveling off


In this Friday, Feb. 9, 2018 file photo, lab technologist Sharda Modi tests a patient's swab for a flu infection at Upson Regional Medical Center in Thomaston, Ga. On Friday, Feb. 16, 2018, a report released by the Centers for Disease Control and Prevention shows the flu season may finally be leveling off.



from Biotech News
Share:

Regeneron Pharmaceuticals (REGN) Upgraded to Strong-Buy at Zacks Investment Research

Regeneron Pharmaceuticals (REGN) Upgraded to Strong-Buy at Zacks Investment Research


The brokerage presently has a $380.00 price objective on the biopharmaceutical company's stock. Zacks Investment Research 's price target indicates a potential upside of 14.05% from the stock's current price.



from Biotech News
Share:

Loudon Investment Management LLC Buys 14,594 Shares of Pfizer Inc.

Loudon Investment Management LLC Buys 14,594 Shares of Pfizer Inc.


Loudon Investment Management LLC lifted its stake in Pfizer Inc. by 29.1% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 64,787 shares of the biopharmaceutical company's stock after buying an additional 14,594 shares during the period.



from Biotech News
Share:

Overnight Health Care: Trump health chief backs CDC research on gun...

Overnight Health Care: Trump health chief backs CDC research on gun...


Secretary of Health and Human Services Alex Azar said Thursday that he would allow his department to conduct research into the causes of gun violence, a major Democratic priority. Democrats on Thursday pushed for lifting a provision that restricts the Centers for Disease Control and Prevention from conducting research into gun violence as part of their response to the mass shooting at a Florida school on Wednesday.



from Biotech News
Share:

Dow Jumps 200 Points as Markets Learn to Stop Worrying and Love Inflation

Dow Jumps 200 Points as Markets Learn to Stop Worrying and Love Inflation


Stocks are rising for a fifth day despite rising producer prices and jobless claims that remained near a 45-year low. The S&P 500 has risen 0.5% to 2712.46 at 9:43 a.m. today, while the Dow Jones Industrial Average has climbed 195.5 points, or 0.8%, to 25,089.02.



from Biotech News
Share:

Flu vaccines 25% effective against worst strain,a

Flu vaccines 25% effective against worst strain,a


This year's vaccines reduce flu cases by about one third, but effectiveness against the most common strain causing the most misery is lower. Flu viruses are quick-change artists.



from Biotech News
Share:

Roche geht auf Einkaufstour in den USA

Roche geht auf Einkaufstour in den USA


(dpa-AFX) Roche begibt sich auf Einkaufstour in den USA und übernimmt Flatiron Health vollständig. Bisher hatten die Svhweizer 12,6 Prozent an dem privat geführten Technologie- und Dienstleistungsunternehmen mit Sitz in New York gehalten, wie das Unternehmen am Donnerstag mitteilte. Die Transaktion ...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Mercks Hoffnungsträger Bavencio scheitert in Lungenkrebs-Studie

Mercks Hoffnungsträger Bavencio scheitert in Lungenkrebs-Studie


(dpa-AFX) Merck hat mit seinem Hoffnungsträger Avelumab (Markenname Bavencio) einen weiteren Rückschlag erlitten: In einer wichtigen Lungenkrebs-Studie verfehlte die Krebsimmuntherapie ihr Endziel, wie Merck und sein Kooperationspartner Pfizer am Donnerstag in Darmstadt und New York mitteilten. Demn...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Victory Capital Management Inc. Sells 7,441 Shares of Alexion Pharmaceuticals, Inc.

Victory Capital Management Inc. Sells 7,441 Shares of Alexion Pharmaceuticals, Inc.


Victory Capital Management Inc. cut its position in shares of Alexion Pharmaceuticals, Inc. by 6.1% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 113,701 shares of the biopharmaceutical company's stock after selling 7,441 shares during the quarter.



from Biotech News
Share:

UPDATE 1-Bristol-Myers to pay $1.85 bln in cancer deal with Nektar

UPDATE 1-Bristol-Myers to pay $1.85 bln in cancer deal with Nektar


Bristol-Myers Squibb Co will pay Nektar Therapeutics $1.85 billion for a global development and profit-sharing deal on a promising Nektar cancer drug, the companies announced on Wednesday. In one of the largest single-drug collaboration deals ever, Nektar will receive $1 billion in cash upfront and Bristol-Myers will purchase about 8.28 million Nektar shares at $102.60 per share, or an equity stake of just under 5 percent of the company.



from Biotech News
Share:

US stocks keep gaining as tech, industrial companies rise

US stocks keep gaining as tech, industrial companies rise


U.S. stocks are rising Thursday as investors continue to snap up shares of companies that do better in times of faster economic growth, such as industrial and technology companies and banks. A round of solid results from companies including Cisco Systems are also sending the market higher.



from Biotech News
Share:

Traders Buy Large Volume of Progenics Pharmaceuticals Call Options

Traders Buy Large Volume of Progenics Pharmaceuticals Call Options


Progenics Pharmaceuticals, Inc. saw unusually large options trading on Tuesday. Investors bought 2,342 call options on the company.



from Biotech News
Share:

First lady brings Valentine's Day cheer to kids in hospital

First lady brings Valentine's Day cheer to kids in hospital


Melania Trump has brought some Valentine's Day cheer to children receiving medical treatment at a private facility on the campus of the National Institutes of Health. She helped one group of kids decorate heart-shaped cookies with white frosting and sprinkles.



from Biotech News
Share:

Neuer Rückschlag für die Alzheimer-Forschung

Neuer Rückschlag für die Alzheimer-Forschung


(dpa-AFX) Die Alzheimer-Forschung erlebt einen weiteren Flop: Der US-Konzern Merck & Co bricht eine weit fortgeschrittene Studie an seinem Alzheimer-Medikament Verubecestat mangels Erfolgsaussichten ab. Ein Expertengremium habe dies empfohlen, teilte der Konzern am Mittwoch in Kenilworth im US-Bunde...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Finanzinvestor Singer bleibt zweitgrößter Stada-Aktionär

Finanzinvestor Singer bleibt zweitgrößter Stada-Aktionär


(dpa-AFX) Beim Arzneimittelhersteller Stada ist der berüchtigte Finanzinvestor Paul Singer weiter zweitgrößter Aktionär. Der US-Amerikaner hielt zum Stichtag 7. Februar noch immer mehr als 15 Prozent an dem Bad Vilbeler Unternehmen, wie aus einer am Mittwoch vorgelegten Stimmrechtsmitteilung hervorg...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Bayer überarbeitet Produktion nach Rüge der US-Gesundheitsbehörde

Bayer überarbeitet Produktion nach Rüge der US-Gesundheitsbehörde


(dpa-AFX) Ein Tadel der US-Gesundheitsbehörde FDA zwingt Bayer zu Änderungen bei der Herstellung einiger Medikamente. "Aufgrund der laufenden Korrekturmaßnahmen und Modernisierungsarbeiten erwarten wir, dass es zu vorübergehenden Versorgungsunterbrechungen kommt, die unser reifes Produktportfolio be...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

First blood test to help diagnose brain injuries gets Us Ok

First blood test to help diagnose brain injuries gets Us Ok


The move means Banyan Biomarkers can commercialize its test, giving the San Diego-based company an edge in the biotech industry's race to find a way to diagnose concussions. The test doesn't detect concussions, but instead measures two proteins present in brain cells.



from Biotech News
Share:

Teva planned for second generic Copaxone to enter market in 2018

Teva planned for second generic Copaxone to enter market in 2018


Israel-based Teva Pharmaceutical Industries said on Tuesday it had anticipated and planned for a second generic competitor to its multiple sclerosis treatment Copaxone to enter the market in 2018. TEL AVIV: Israel-based Teva Pharmaceutical Industries said on Tuesday it had anticipated and planned for a second generic competitor to its multiple sclerosis treatment Copaxone to enter the market in 2018.



from Biotech News
Share:

Verify 2 hour ago 7:24 p.m.VERIFY | Are there toxins in Johnson's baby shampoo?

Verify 2 hour ago 7:24 p.m.VERIFY | Are there toxins in Johnson's baby shampoo?


The post has been shared over 800 times. Since January 17, other similar posts have also popped up on Facebook.



from Biotech News
Share:

Chemist stole cyanide to kill rodents, DA says. It nearly ended up in the water supply.

Chemist stole cyanide to kill rodents, DA says. It nearly ended up in the water supply.


Chemist Richard O'Rourke, 60, had a plan to kill the rodents on his Warrington, Pennsylvania, property , but he almost polluted the water supply in the process, according to prosecutors. Upper Gwynedd Township Police had received a tip from another chemist at Merck & Co, a pharmaceutical company, that potassium cyanide had been stolen from a laboratory, according to Montgomery County District Attorney Kevin Steele.



from Biotech News
Share:

Press release distribution, EDGAR filing, XBRL, regulatory filings

Press release distribution, EDGAR filing, XBRL, regulatory filings


This country report and accompanying data annex provide a comprehensiv... )--The "Saudi Arabia Telecoms Market Report 2017" report has been added to ResearchAndMarkets.com's offering. This country report and accompanying data annex provide a compreh... )--Osram, a global high-tech lighting company, today announced the launch of its Digital Lighting Systems blog, which will serve as a resource to guide discussions ... )--Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Johnson & Johnson between February 22, 2013 and February 7, 201... )--Technavio's market research report on the global portable pressure washers market provides an analysis of the most important trends and drivers.



from Biotech News
Share:

Fortress Biotech (FBIO) Stock Rating Lowered by Zacks Investment Research

Fortress Biotech (FBIO) Stock Rating Lowered by Zacks Investment Research


According to Zacks, "Fortress Biotech, Inc. is a biopharmaceutical company. The company is engaged in acquiring, developing and commercializing novel pharmaceutical and biotechnology products.



from Biotech News
Share:

MediciNova Announces Closing of Underwritten Public Offering of Common Stock

MediciNova Announces Closing of Underwritten Public Offering of Common Stock


MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market and the JASDAQ Market of the Tokyo Stock Exchange , announced today the closing of the previously announced underwritten public offering of 4,419,890 shares of its common stock at a price to the public of $9.05 per share. The gross proceeds to MediciNova from this offering were approximately $40.0 million, before deducting the underwriting discount and other estimated offering expenses.



from Biotech News
Share:

The Wall Street Journal: Walgreens makes takeover bid for drug distributor AmerisourceBergen

The Wall Street Journal: Walgreens makes takeover bid for drug distributor AmerisourceBergen


Walgreens Boots Alliance Inc. has made a takeover approach to drug distributor AmerisourceBergen Corp., a move that could help boost profitability at the drugstore giant and insulate it against external threats in an increasingly competitive health-care landscape. Representatives of Walgreens Chief Executive Stefano Pessina reached out several weeks ago to representatives of Amerisource CEO Steven Collis, according to people familiar with the matter.



from Biotech News
Share:

Woman had 14 worms pulled from her eye after rare infection

Woman had 14 worms pulled from her eye after rare infection


This undated photo provided by the Centers for Disease Control and Prevention shows Thelazia gulosa, a type of eye worm seen in cattle in the northern United States and southern Canada, but never before in humans. An Oregon woman who had worms coming out of her eye is being called the first known human case of a parasitic infection spread by flies.



from Biotech News
Share:

Finanzen: Solarthermie : Solarthermie

Mit einer Solarthermie-Anlage können Sie Ihre Energiekosten verringern und profitieren von staatlichen Förderungen. Wie Sie am günstigsten zu Ihrer eigenen Solaranlage kommen.

from Finanztip Feed
Supported by Video Collection
Share:

A woman wears a facial surgical mask in an effort to

A woman wears a facial surgical mask in an effort to


The Centers for Disease Control and Prevention says the flu has further tightened its grip on the U.S. and warns the season is now as bad as the swine flu epidemic nine years ago. A woman wears a facial surgical mask in an effort to protect herself from the influenza virus outbreak while riding the MARTA rail rapid transit system in Atlanta on Feb. 8, 2018 That's what Japanese drug maker Shionogi claims its new flu treatment can do, the Wall Street Journal reports , but the compound that could relieve one of the worst flu seasons in years wouldn't hit U.S. shelves until at least 2019.



from Biotech News
Share:

Die Rückverfolgung von Smartphone-Bildern verhindern

Die Rückverfolgung von Smartphone-Bildern verhindern


Kriminaltechniker können über die Patronenhülse und ein Projektil eine Tatwaffe identifizieren. Seit kurzem lassen sich auch mit dem Handy geschossene Fotos zu dem betreffenden Telefon zurückverfolgen. Im Gegensatz zu dem Verfahren bei Munition und Waffen, kann man (derzeit noch) die Nachverfolgung von Bildern leicht aushebeln.

Bei den Fotos werden minimale Fehler in der Belichtung gesucht. Dadurch entsteht ein Muster, dass nur zu einem Gerät passt. Dieses Verfahren, genannt PRNU (Photo-Response Non-Uniformity), kannst du mit einer beliebigen Bildbearbeitungssoftware unterlaufen.

Mit Bildbearbeitungssoftware mehrere Arbeitsschritte notwendig

Dazu ist eigentlich nur die Bearbeitung der Helligkeits- und Kontrastwerte des betreffenden Fotos erforderlich. Allerdings müssen die Fotos mindestens fünfmal auf diese Weise bearbeitet und vor jedem Arbeitsschritt als JPG neu gespeichert werden. Um ganz sicher zu gehen, dass die Belichtungsfehler nicht zurückverfolgbar sind, sollte man auf wesentlich mehr Bearbeitungsschritte Wert legen, da die Forscher der Universität in Buffalo eine Trefferquote von über 99 Prozent angeben.

In einem Arbeitsschritt zur Anonymisierung

Wenn du dir es etwas leichter machen willst, kannst du auch eine Anonymisierungs-Software verwenden. Die gibt es unter dem Namen PRNU Decompare auf der Webseite von Sourceforge kostenlos erhältlich ist. Mit diesem Tool kannst du die PRNU-Muster unleserlich machen, bearbeiten oder auch komplett entfernen. Und das ohne die Bildqualität negativ zu beeinflussen.



Supported by World News Digest
Share:

CareFusion (CFN) versus Neurometrix (NURO) Head-To-Head Comparison

CareFusion (CFN) versus Neurometrix (NURO) Head-To-Head Comparison


CareFusion and Neurometrix are both medical equipment, supplies & distribution - nec companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, dividends, institutional ownership, profitability, valuation, analyst recommendations and risk. CareFusion has higher earnings, but lower revenue than Neurometrix.



from Biotech News
Share:

Body of man found off the coast of La Jolla

Body of man found off the coast of La Jolla


The San Diego Medical Examiner's Office is working Monday to identify a body that was found a few miles off the coast of La Jolla. Mariners on a private boat reported seeing the corpse floating in the water around 7:30 Sunday morning about two-and-a-half miles from the shore.



from Biotech News
Share:

Zacks: Analysts Set $111.67 Target Price for China Biologic Products Holdings, Inc.

Zacks: Analysts Set $111.67 Target Price for China Biologic Products Holdings, Inc.


China Biologic Products Holdings, Inc. has earned a consensus broker rating score of 1.00 from the three analysts that provide coverage for the company, Zacks Investment Research reports. Three analysts have rated the stock with a strong buy rating.



from Biotech News
Share:

CDC needs world-class scientist in top job after last director resigned in scandal

CDC needs world-class scientist in top job after last director resigned in scandal


Offices of the Centers for Disease Control and Prevention in Atlanta. The CDC is awaiting a new director after Brenda Fitzgerald stepped down in January.



from Biotech News
Share:

Man's body found off the coast of La Jolla

Man's body found off the coast of La Jolla


People on a private boat found the unidentified corpse floating in the water about 2.5 miles from Children's Pool about 7:30 a.m., San Diego Fire-Rescue spokeswoman Monica Munoz said.



from Biotech News
Share:

Insulin quality questions have diabetes experts scrambling

Insulin quality questions have diabetes experts scrambling


Pharmacist and researcher Alan Carter recently published study finding that a variety of insulin vials he tested seemed to hold far less of the life-saving hormone than they should. Carter and colleagues did the testing in the labs of contract researcher MRIGlobal, where he worked until recently.



from Biotech News
Share:

Amgen findet keine geeigneten Übernahmeziele für 27-Mrd-US-Dollar Kriegskasse

Amgen findet keine geeigneten Übernahmeziele für 27-Mrd-US-Dollar Kriegskasse


(dpa-AFX) Der weltweit größte Biotech-Konzern Amgen hat Probleme, Übernahmeziele zu finden. Man sei sehr stark am Suchen nach interessanten Unternehmen, sagte Finanzvorstand David Meline der "Financial Times" (FT, Montag). Allerdings seien die Bewertungen sehr hoch. Man beobachte alle angekündigten ...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Hologic (HOLX) Rating Reiterated by Royal Bank of Canada

Hologic (HOLX) Rating Reiterated by Royal Bank of Canada


's stock had its "hold" rating restated by research analysts at Royal Bank of Canada in a research report issued on Friday. They presently have a $44.00 price objective on the medical equipment provider's stock.



from Biotech News
Share:

Wireless-Kopfhörer „Bose SoundSport Free“ jetzt auch in Deutschland erhältlich

Wireless-Kopfhörer „Bose SoundSport Free“ jetzt auch in Deutschland erhältlich


Kabellose Kopfhörer gibt es wie Sand am Meer. Wenn neue Modelle auf den Markt kommen, dann gehen sie meist in der Menge unter. Aber nicht der Verkaufsstart der neuen Wireless Headphones vom Premium-Hersteller Bose.

Am 06. Februar 2018 verkündete Bose, dass die Kopfhörer SoundSport Free nun auch in Deutschland erhältlich sind. In den USA sind sie bereits seit September 2017 zum Preis von knapp 250 US-Dollar in den Stores zu finden.

Komplett kabelloser Betrieb

Die In-Ear-Kopfhörer SoundSport Free sind komplett kabellos und auch die weiter Ausstattung kann sich sehen lassen. Der Tragekomfort ist nach eigenen Aussagen für Höchstleistungen beim Training ausgelegt.

Verbesserte Technik

Die Technik, insbesondere die Schaltungen und die Bluetooth-Antenne wurden optimiert und neu ausgerichtet, damit immer eine optimale Verbindung zu deinem Smartphone hergestellt werden kann. Außerdem sind sie durch die IPX4-Zertifizierung optimal gegen Feuchtigkeit durch Regen oder Schweiß geschützt.

Einer der Buds verfügt über ein Bedienelement, mit dem du die Wiedergabe pausieren kannst oder den vorigen/nächsten Titel startest. Außerdem lassen sich damit eingehende Telefonate annehmen und beenden.

Zwischen 5 bis 15 Stunden Musikgenuss

Eine Akkuladung reicht für fünf Stunden Musikhören aus. Die mitgelieferte Aufbewahrungsbox bringt durch integrierte Akkus zusätzliche zehn Stunden Laufzeit mit. Ein weiterer Clou der Aufbewahrungsbox ist die Schnellladefunktion. 15 Minuten Ladezeit reichen für 45 Minuten Musikhören aus.

Etui mit Ladefunktion

Zum Lieferumfang gehört natürlich auch die App Bose Connect für Android und iPhone/iPad, die einen Equalizer und weitere Einstellungsmöglichkeiten für die Bose Ear-Buds enthält.

Der offizielle Verkaufspreis für die Kopfhörer Bose SoundSport Free liegt bei moderaten 199,95 Euro. Für gute Kopfhörer ist das ein durchaus akzeptabler Betrag.

Kopfhörer verloren?

Mit der Bose Connect App kannst du auch verlorengegangene Kopfhörer über die Find-my-Buds-Funktion wiederfinden.



Supported by World News Digest
Share:

Comparing Medifast

Comparing Medifast


Medifast and Simply Good Foods are both small-cap special foods & welbeing products companies, but which is the better business? We will compare the two companies based on the strength of their valuation, dividends, profitability, institutional ownership, risk, analyst recommendations and earnings. Medifast presently has a consensus target price of $72.00, suggesting a potential upside of 7.95%.



from Biotech News
Share:

Alnylam Pharmaceuticals (ALNY) Price Target Cut to $118.00 by Analysts at Morgan Stanley

Alnylam Pharmaceuticals (ALNY) Price Target Cut to $118.00 by Analysts at Morgan Stanley


The firm currently has an "equal weight" rating on the biopharmaceutical company's stock. Morgan Stanley's price objective indicates a potential upside of 1.79% from the company's current price.



from Biotech News
Share:

Teenager has a big heart for helping other kids

Teenager has a big heart for helping other kids


Sommerville Hill walks the halls at Carrollton High School with a severe heart condition. But she doesn't let that slow her down.



from Biotech News
Share:

Analysts Anticipate Endo International plc - (ENDP) to Announce $0.63 Earnings Per Share

Analysts Anticipate Endo International plc - (ENDP) to Announce $0.63 Earnings Per Share


Brokerages predict that Endo International plc - will announce earnings per share of $0.63 for the current quarter, according to Zacks Investment Research . Six analysts have made estimates for Endo International's earnings, with the highest EPS estimate coming in at $0.67 and the lowest estimate coming in at $0.58.



from Biotech News
Share:

Jefferies Group Reiterates $72.00 Price Target for Cardinal Health

Jefferies Group Reiterates $72.00 Price Target for Cardinal Health


The firm presently has a "hold" rating on the stock. Jefferies Group's price target points to a potential upside of 7.91% from the stock's current price.



from Biotech News
Share:

MannKind Co. (MNKD) Short Interest Up 4.4% in January

MannKind Co. (MNKD) Short Interest Up 4.4% in January


MannKind Co. was the target of a large increase in short interest in the month of January.



from Biotech News
Share:

Firefox: Vorsicht, wenn fremde Webseiten zum Update raten

Firefox: Vorsicht, wenn fremde Webseiten zum Update raten


Derzeit sind Firefox-User verstärkt Angriffen durch Schadware ausgesetzt. Die Masche: Webseiten versuchen dem Nutzer vorzugaukeln, dass der Firefox-Browser ein Update benötigt, dass man über diese Seite manuell herunterladen und installieren kann. Aber anstatt eines Updates, wird aber nur Schadsoftware installiert.

Kein manuelles Update von fremden Webseiten durchführen

Die Update-Meldung auf den Webseiten bedienen sich unterschiedlicher Mittel, um die User in die Irre zu führen. Da wird beispielsweise der Browser auf Vollbildmodus umgeschaltet oder es werden Pop-Ups eingesetzt. Ziel ist aber immer, dass man sofort ein manuelles Update durchführen soll.

Natürlich wird der Browser nicht aktualisiert,  stattdessen werden Erweiterungen mit wohlklingenden Namen wie Time Tracking, FF AdBlock Protection oder FF Helper Checker installiert, die sich nicht einfach wieder entfernen lassen.

Die Malware-Add-Ons leiten „normale“ Links auf Werbe-Webseiten um, schleusen Werbebanner ein und nutzen die Rechenleistung deines Computers um Kryptowährungen wie Monero zu schürfen. Außerdem verhindern die Erweiterungen den Zugriff auf das Add-ons-Menü deines Firefox-Browsers.

Gegenmaßnahmen

Hast du dir eine dieser Malware-Erweiterungen eingefangen, rufst du die Firefox-Fehlerbehebung auf. Dazu gibst du in die Adresszeile den Befehl about:support ein und bestätigst mit der Taste [Enter].

Wähle auf der Seite Informationen zur Fehlerbehebung rechts oben die Option Mit deaktivierten Add-ons neu starten aus und bestätige den Warnhinweis mit dem Button Neu starten.

Dann öffnest du über das Drei-Balken-Symbol den Menüpunkt Add-ons und löschst die schädlichen und/oder unbekannten Erweiterungen.

Alternativ lässt sich über about:support der Firefox auch bereinigen. Hier werden dann automatisch alle Einstellungen und Erweiterungen entfernt. Deine gespeicherten Passwörter und Lesezeichen bleiben aber erhalten.

Spätestens jetzt sollte nach einem weiteren Browser-Neustart die Schadsoftware verschwunden sein.

Fazit

Um sich vor dieser Malware zu schützen, solltest du dich generell von besuchten Webseiten verleiten lassen, Updates herunterzuladen. Standardmäßig ist Firefox so eingestellt, dass neue Updates automatisch heruntergeladen und installiert werden.



Supported by World News Digest
Share:

Amid overdose epidemic, Pennsylvania isn't tracking the drugs killing people

Amid overdose epidemic, Pennsylvania isn't tracking the drugs killing people


In this Feb. 2, 2017, file photo, used needles litter the ground at an open air drug market along Conrail train tracks in the Kensington section of Philadelphia. Drug overdose deaths in the U.S. have skyrocketed.



from Biotech News
Share:

What Your Doctor Wants You to Ask About Metastatic Breast Cancer

What Your Doctor Wants You to Ask About Metastatic Breast Cancer


This promotional content is brought to you by Eisai Inc. Dr. Shayma Master Kazmi has been compensated for her time developing this article with Eisai. When you're diagnosed with metastatic breast cancer, your life can feel like it's been turned upside down.



from Biotech News
Share:

The Latest: Trudeau meets with California's top leaders

The Latest: Trudeau meets with California's top leaders


Canadian Prime Minister Justin Trudeau, right, and Devin Wenig, chief executive of eBay, pose for a photo as they meet Thursday, Feb. 8, 2018 in San Francisco. Canadian Prime Minister Justin Trudeau visited San Francisco on Thursday.



from Biotech News
Share:

Flu season still getting worse; now as bad as 2009 swine flu

Flu season still getting worse; now as bad as 2009 swine flu


The flu has further tightened its grip on the U.S. This season is now as bad as the swine flu epidemic nine years ago. A government report out Friday shows 1 of every 13 visits to the doctor last week was for fever, cough and other symptoms of the flu.



from Biotech News
Share:

This flu season is the worst in nearly a decade - and it's not getting better

This flu season is the worst in nearly a decade - and it's not getting better


In severe flu seasons like this one, the CDC estimates that up to 56,000 people, mostly older adults, die from complications. Health officials say flu season continues to get worse, and there are weeks of suffering ahead.



from Biotech News
Share:

Regeneron's coming late to a group of drugs that's already...

Regeneron's coming late to a group of drugs that's already...


Regeneron's coming late to a group of drugs that's already worth billions - here's why the company thinks it can still compete The drug, cemiplimab, is a checkpoint inhibitor, a kind of drug that's part of a new class of cancer medications known as immunotherapy. There are already a handful of competitors that have gotten their versions of the drug approved, but t hat hasn't stopped Regeneron from pursuing it.



from Biotech News
Share:

Alexion Pharmaceuticals, Inc. (ALXN) SVP Sells $206,333.94 in Stock

Alexion Pharmaceuticals, Inc. (ALXN) SVP Sells $206,333.94 in Stock


Alexion Pharmaceuticals, Inc. SVP Heidi L. Wagner sold 1,774 shares of the stock in a transaction on Thursday, February 8th. The stock was sold at an average price of $116.31, for a total value of $206,333.94.



from Biotech News
Share:

JPM Conference Takeaways: Biotech and Biopharma Set for Growth in 2018

JPM Conference Takeaways: Biotech and Biopharma Set for Growth in 2018


Coming off a year that saw a record number of new drug approvals, significant scientific breakthroughs and a year-end tax reform package that both significantly lowers corporate taxes and provides the long-awaited tax repatriation holiday, it's not surprising that biotech investors, executives and advisers were in a good mood as they gathered in San Francisco this year for the J.P. Morgan Healthcare Conference. The skies may have been cloudy, but spirits were high, fueled by expectations for a resurgence in U.S. M&A deals, continued growth in healthcare venture fundraising, and the promise of big data and other technologies.



from Biotech News
Share:

Finanzen: Ratenkredit umschulden : Umschuldung

Die Zinsen für Kredite sind zuletzt deutlich gesunken. Davon können Sie profitieren, indem Sie Ihren bestehenden Kredit in einen günstigeren umwandeln.

from Finanztip Feed
Supported by Video Collection
Share:

Teva chief reports 'strong progress' in restructuring plan

Teva chief reports 'strong progress' in restructuring plan


File - In this Sunday, Dec. 17, 2017 file photo, workers protest outside the Teva Pharmaceutical Industries factory as the block a main road in Jerusalem. The chief executive of Teva Pharmaceuticals on Thursday said he is making "strong progress" on the company's restructuring plan, even as the company posted a huge loss and forecast a challenging 2018.



from Biotech News
Share:

Teva rutscht wegen Milliardenabschreibungen tief in die roten Zahlen

Teva rutscht wegen Milliardenabschreibungen tief in die roten Zahlen


(dpa) Der kriselnde israelische Teva-Konzern hat im vergangenen Jahr von der Übernahme des Generikaherstellers Actavis profitiert. Unter dem Strich musste die Ratiopharm-Mutter jedoch wegen hoher Abschreibungen auf das US-Generikageschäft einen Verlust von 16,3 Milliarden Dollar verkraften - nach ei...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Novartis-Tochter Sandoz erleidet Rücksetzer mit Biosimilar für Advair

Novartis-Tochter Sandoz erleidet Rücksetzer mit Biosimilar für Advair


(dpa-AFX) Die Novartis-Tochter Sandoz hat mit ihrem Zulassungsantrag für das Biosimilar Advair einen Rücksetzer erlitten. Wie es in einem Statement der Generika-Tochter heißt, das AWP vorliegt, hat Sandoz von der US-Gesundheitsbehörde FDA einen so genannten Complete Letter of Response erhalten. Eine...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Drugmaker GSK wins fresh Advair reprieve as Novartis copy delayed

Drugmaker GSK wins fresh Advair reprieve as Novartis copy delayed


GlaxoSmithKline has won another reprieve for its blockbuster Advair lung drug after U.S. regulators delayed approval of a generic copy from Novartis's Sandoz division. The Swiss drugmaker said in an emailed statement on Thursday it had received a so-called complete response letter from the U.S. Food and Drug Administration and a generic Advair launch this year was now "highly unlikely".



from Biotech News
Share:

Artifacts from Indiana monument moved due to flood basement

Artifacts from Indiana monument moved due to flood basement


A leak that sent water into the basement of a historic monument in downtown Indianapolis has prompted curators to move a collection of artifacts documenting Indiana's role in the Civil War. The Indianapolis Star reports that the Soldiers and Sailors Monument's artifacts, including a cannon, were moved a few blocks north to the Indiana War Memorial.



from Biotech News
Share:

Press release distribution, EDGAR filing, XBRL, regulatory filings

Press release distribution, EDGAR filing, XBRL, regulatory filings


Morgan Stanley will act as underwriter for ... )--Six Flags Entertainment Corporation , the world's largest regional theme park company, today announced that its board of directors declared a first... )--Validus Holdings, Ltd. announced today that its Board of Directors has declared a quarterly cash dividend of $0.38 per com... )--TIER REIT, Inc. , a Dallas-based real estate investment trust, announced today that its board of directors has declared a cash distribution of $0.18 per share of...



from Biotech News
Share:

Finanzen: Zinsen auf Steuererstattungen : Zinsen auf Steuererstattung

Wer seine Steuererklärung freiwillig abgibt und lange auf eine Steuerrückerstattung warten muss, bekommt Zinsen vom Finanzamt. Die gibt es ab dem 16. Monat, nachdem das Steuerjahr zu Ende gegangen ist.

from Finanztip Feed
Supported by Video Collection
Share:

Finanzen: Private Krankenversicherung für Arbeitslose : Private Krankenversicherung für Arbeitslose

Wer Arbeitslosengeld bezieht, ist automatisch gesetzlich krankenversichert. Privatversicherte können sich davon befreien oder ihren PKV-Vertrag ruhen lassen.

from Finanztip Feed
Supported by Video Collection
Share:

A new pill to treat HIV just got approved - and it could shake up a $22 billion market

A new pill to treat HIV just got approved - and it could shake up a $22 billion market


The pill, made by Gilead Sciences, contains bictegravir, along with emtricitabine and tenofovir alafenamide, two drugs that are considered the "backbone" of HIV treatments. Of the three treatments contained in the pill, bictegravir is the only totally new element.



from Biotech News
Share:

SCHOTT erweitert Produktion für beschichtete Pharmafläschchen

SCHOTT erweitert Produktion für beschichtete Pharmafläschchen


SCHOTT hat deutlich in die Produktion für beschichtete Fläschchen am badischen Standort Müllheim investiert. Da Pharmaunternehmen immer mehr sensible Medikamente auf den Markt bringen, die speziell verpackt werden müssen, steigt das Interesse an Fläschchen mit Innenbeschichtung stetig an. SCHOTT bie...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Roche kommt mit Ignyta-Übernahme voran

Roche kommt mit Ignyta-Übernahme voran


(dpa-AFX) Der Pharmakonzern Roche kommt mit der Übernahme der US-Firma Ignyta voran. Roche seien knapp 57,4 Millionen Ignyta-Anteile angedient worden, teilte das Unternehmen am Donnerstag mit. Nach Ablauf der Angebotsfrist halten die Basler also 84,71 Prozent am Onkologieunternehmen. Weitere 3,43 Mi...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Finanzen: Schönheitsreparaturen im Mietrecht : Schönheitsreparaturen

Dass der Mieter Schönheitsreparaturen durchführen muss, steht in fast allen Mietverträgen. Doch die Klauseln sind oft unwirksam.

from Finanztip Feed
Supported by Video Collection
Share:

Insulin quality questions have diabetes experts scrambling

Insulin quality questions have diabetes experts scrambling


In this Jan. 30, 2018, photo Pharmacist and researcher Alan Carter poses for a photo in Kansas City, Mo. Carter raised a stir with his recently published study finding that a variety of insulin vials he tested seemed to hold far less of the life-saving hormone than they should.



from Biotech News
Share:

GlaxoSmithKline: Gewinnplus von Generikakonkurrenz abhängig

GlaxoSmithKline: Gewinnplus von Generikakonkurrenz abhängig


(dpa-AFX) Der britische Pharmakonzern GlaxoSmithKline will im laufenden Geschäftsjahr dank neuer Medikamente wachsen. Dennoch bleibt der Konzern von seinen alten Blockbustern abhängig - die unter steigendem Druck durch Generika stehen. So erwartet GlaxoSmithKline für 2018 ein Plus beim bereinigtem E...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Fortress Biotech (FBIO) Upgraded at Zacks Investment Research

Fortress Biotech (FBIO) Upgraded at Zacks Investment Research


According to Zacks, "Fortress Biotech, Inc. is a biopharmaceutical company. The company is engaged in acquiring, developing and commercializing novel pharmaceutical and biotechnology products.



from Biotech News
Share:

Contrasting Simply Good Foods

Contrasting Simply Good Foods


Simply Good Foods and Medifast are both small-cap consumer staples companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, profitability, risk, earnings, valuation and institutional ownership. Medifast pays an annual dividend of $1.92 per share and has a dividend yield of 2.9%.



from Biotech News
Share:

Finanzen: Ratgeber Ratenkredit : Kredit und Darlehen

Wer einen Kredit aufnehmen will, erhält über Vergleichsportale Angebote unterschiedlicher Banken. Auf dem Weg zum Kredit sollten Verbraucher mehr als ein Portal nutzen.

from Finanztip Feed
Supported by Video Collection
Share:

Pharmaceutical company touts 'breakthrough' cancer treatment

Pharmaceutical company touts 'breakthrough' cancer treatment


Patients participating in a trial for a new lung cancer treatment have shown signs of improved health, leading the pharmaceutical company behind the study to hail a major "breakthrough" in the field . The American company Bristol-Myers Squibb reported Monday that lung cancer patients treated with a combination of its anti-tumor drug Opdivo and its melanoma drug Yervoy showed encouraging results .



from Biotech News
Share:

Finanzen: Investmentsteuerreformgesetz : Investmentsteuerreformgesetz

Ab 2018 werden alle Fonds und ETFs steuerlich gleich behandelt. Abgeltungssteuer fällt künftig jährlich auf eine Pauschale an. Worauf Sparer achten sollten.

from Finanztip Feed
Supported by Video Collection
Share:

UPDATE 3-AmerisourceBergen sees $60 mln hit from troubled Memphis plant

UPDATE 3-AmerisourceBergen sees $60 mln hit from troubled Memphis plant


Operations at the automated facility in Memphis, its largest, were suspended in December following an inspection by the U.S. drug regulator. The plant, which makes medicines in doses that are not commercially available, was acquired as part of AmerisourceBergen's 2015 buy of PharMEDium Healthcare Holdings.



from Biotech News
Share:

Sanofi von starkem Euro und schwachem Diabetes-Geschäft gebremst

Sanofi von starkem Euro und schwachem Diabetes-Geschäft gebremst


(dpa-AFX) Der Pharmakonzern Sanofi hat im vierten Quartal deutlich unter dem starken Euro und seinem schwachen Diabetes-Geschäft gelitten. Zudem musste der Konzern das Mittel Dengvaxia, eine Impfung gegen das Dengue-Fieber, vom Markt nehmen, was den Gewinn zusätzlich belastete. Der um Sonderposten b...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Array melanoma drugs show significant survival versus Roche drug in study

Array melanoma drugs show significant survival versus Roche drug in study


REUTERS: A combination of experimental drugs from Array BioPharma Inc kept patients with advanced melanoma associated with a common gene mutation alive for nearly three years and twice as long as a rival Roche Holding AG medicine, according to data from a late stage study released on Tuesday. The oral drugs, encorafenib and binimetinib, are awaiting a U.S. approval decision by June 30 based on promising data on their ability to stall disease worsening, or progression-free survival .



from Biotech News
Share:

Fetal alcohol disorders more common than thought, study says

Fetal alcohol disorders more common than thought, study says


More children have been affected by drinking during pregnancy than previously thought, according to a study published Tuesday in the Journal of the American Medical Association. Up to one in 20 American kids falls somewhere on the spectrum of disorders caused by maternal drinking, according to the study's more conservative estimate.



from Biotech News
Share:

Rapid flu tests only 50 to 70 percent reliable, CDC says

Rapid flu tests only 50 to 70 percent reliable, CDC says


Dominic Sy didn't feel well, so he came to an emergency room to get a rapid flu test. It requires a swab deep in the nasal cavity for a proper sample, but the results, which are back in around five minutes, can produce false negatives -- meaning a patient with the flu may not know it.



from Biotech News
Share:

The 8 Alabama communities hit hardest by flu-related deaths

The 8 Alabama communities hit hardest by flu-related deaths


The Centers for Disease Control and Prevention said the flu is now "widespread" across 48 states, a drop of one state from the previous week with Oregon joining Hawaii in reporting lower activity levels. At least 17 children died from the flu last week.



from Biotech News
Share:

Bristol-Myers Wins, But Not in an Eagles-Super-Bowl Way: Gadfly

Bristol-Myers Wins, But Not in an Eagles-Super-Bowl Way: Gadfly


Victories come in multiple sizes. And Bristol-Myers Squibb Co.' s latest isn't quite an Eagles Super Bowl win.



from Biotech News
Share:

Fortress Biotech (FBIO) and Synlogic (SYBX) Financial Survey

Fortress Biotech (FBIO) and Synlogic (SYBX) Financial Survey


Synlogic and Fortress Biotech are both small-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, dividends, risk, earnings, analyst recommendations, valuation and institutional ownership. Synlogic currently has a consensus price target of $18.75, suggesting a potential upside of 88.44%.



from Biotech News
Share:

Biosimilars Council Sides with Pfizer in Antitrust Dispute with J&J

Biosimilars Council Sides with Pfizer in Antitrust Dispute with J&J


As we previously reported , on September 20, 2017, Pfizer filed an antitrust lawsuit against Johnson & Johnson in the U.S. District Court for the Eastern District of Pennsylvania alleging that J&J has engaged in an anticompetitive scheme to protect its Remicade product. On November 28, 2017, J&J filed a motion to dismiss Pfizer's complaint alleging that Pfizer did not plead facts "showing that [J&J]'s discounts and rebates, rather than Pfizer's own unwillingness to offer lower prices on [Pfizer's] Inflectra or bundled discounts on Pfizer's many profitable, billion-dollar products, are the cause of Inflectra' s alleged poor record to date."



from Biotech News
Share:

Johnson & Johnson falls on report that lawsuits could expose damaging documents

Johnson & Johnson falls on report that lawsuits could expose damaging documents


Johnson & Johnson has been ordered to pay $55 million to a woman who claims its talcum powder caused her ovarian cancer, the second such judgment against the manufacturer in three months. Johnson's baby powder is squeezed from its container.



from Biotech News
Share:

Nutraceutical Int'l (NUTR) vs. Simply Good Foods (SMPL) Critical Survey

Nutraceutical Int'l (NUTR) vs. Simply Good Foods (SMPL) Critical Survey


Nutraceutical Int'l and Simply Good Foods are both small-cap non-cyclical consumer goods & services companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, analyst recommendations, valuation, institutional ownership, dividends, earnings and risk. This is a breakdown of current ratings and target prices for Nutraceutical Int'l and Simply Good Foods, as reported by MarketBeat.com.



from Biotech News
Share:

Mannatech (MTEX) Rating Lowered to Sell at ValuEngine

Mannatech (MTEX) Rating Lowered to Sell at ValuEngine


Shares of Mannatech remained flat at $$14.45 during mid-day trading on Friday. 8,197 shares of the company were exchanged, compared to its average volume of 4,417.



from Biotech News
Share:

Vertex Pharmaceuticals: Valuation Gets Steep Despite CF Dominance

Vertex Pharmaceuticals: Valuation Gets Steep Despite CF Dominance


With a $40 billion valuation, expectations have risen quite a bit to the extent that investors either expect domination of the CF market soon, or expansion outside this market. Vertex Pharmaceuticals is a leading play to treat cystic fibrosis .



from Biotech News
Share:

Supermarket deli closes due to listeria concerns

Supermarket deli closes due to listeria concerns


Stop & Shop officials say they discovered the meats and cheese sold at their Warwick location may have been exposed to the bacteria between Jan. 18 and Feb. 2. The chain says there were no confirmed illnesses, but they have closed the deli area "out of an abundance of caution." Customers who purchased the items may contact store management.



from Biotech News
Share:

ValuEngine Upgrades Rosetta Genomics (ROSG) to Sell

ValuEngine Upgrades Rosetta Genomics (ROSG) to Sell


Separately, Barrington Research cut Rosetta Genomics from an "outperform" rating to a "market perform" rating in a research report on Monday, December 18th. Rosetta Genomics traded down $0.06 during trading on Friday, reaching $0.50.



from Biotech News
Share:

US-Steuerreform drückt Pharmariesen Merck & Co ins Minus

US-Steuerreform drückt Pharmariesen Merck & Co ins Minus


(dpa) Hohe Sonderbelastungen wegen der US-Steuerreform haben den Pharmakonzern Merck & Co im vierten Quartal trotz steigender Erlöse in die roten Zahlen gedrückt. Eine 2,6 Milliarden Dollar schwere Abschreibung riss die Bilanz mit 872 Millionen Dollar (700 Millionen Euro) ins Minus, wie der US-Konze...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Nestle zieht sich aus dem Rennen um Merck-Sparte zurück

Nestle zieht sich aus dem Rennen um Merck-Sparte zurück


(dpa-AFX) Der Darmstädter Pharma- und Spezialchemiekonzern Merck stößt einem Medienbericht zufolge auf schwindendes Interesse für sein zum Verkauf stehendes Geschäft mit rezeptfreien Medikamenten. Der Schweizer Nestle-Konzern habe sich aus dem Rennen zurückgezogen, berichtete die Nachrichtenagentur ...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Stada-Eigner nehmen letzte Hürde für Übernahme

Stada-Eigner nehmen letzte Hürde für Übernahme


(dpa) Die Finanzinvestoren Bain und Cinven haben die letzte Hürde für die Übernahme des Pharmakonzerns Stada genommen. Auf einer außerordentlichen Hauptversammlung am Freitag in Frankfurt segneten die Aktionäre einen Gewinnabführungs- und Beherrschungsvertrag zwischen den Eignern und dem Grippostad-...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Darum solltest du die WhatsApp-Kamera nicht benutzen

Darum solltest du die WhatsApp-Kamera nicht benutzen


Fotos sind über WhatsApp schnell geschossen und werden anschließend direkt über den Messenger-Dienst versendet. Allerdings solltest du die Kamera-Funktion von WhatsApp meiden.

Der Grund hierfür ist einmal nicht der Datenschutz oder eine Sicherheitslücke, sondern die Qualität der Bilder. Und mit Android-Smartphones macht WhatsApp besonders schlechte Fotos.

WhatsApp schießt schlechte Fotos

Das liegt nicht nur an der Kompression der Bilddaten, sondern am Betriebssystem des verwendeten Smartphones. Es nutzt die zur Verfügung gestellte Schnittstelle, kann aber nicht auf alle Funktionen der Kamera zugreifen.

So kann WhatsApp beispielsweise auf keine erweiterten Kamera-Funktionen, wie HDR oder eine automatische Kontrastanpassung, zugreifen. Stattdessen kommen nur die Basisfunktionen zur Anwendung.

Bilder aus der Galerie verwenden

Besser ist es, mit der „normalen“ Kamera-App zu fotografieren und die Bilder bei WhatsApp über das Büroklammer-Symbol zu versenden.

Auch wenn beim iPhone die Qualitäts-Unterschiede nicht so gravierend ausfallen wie bei Android, sollte man generell auf die WhatsApp-Fotofunktion verzichten.



Supported by World News Digest
Share:

China commits US$1.3b in venture funds for British biotech firms

China commits US$1.3b in venture funds for British biotech firms


Future Planet Capital and Eight Great Technologies will invest the funds in Britain's most innovative biotech, medicine and life sciences companies China's increasing zeal for improving biotechnology and medical services is music to the ears of the British government after two venture capital firms received 8 billion yuan in funding commitments from mainland investors during Prime Minister Theresa May's three-day visit last week. Future Planet Capital and Eight Great Technologies signed the memorandums of understanding with Chinese investment firms, which was witnessed by Liam Fox, Secretary of State for International Trade, which will invest the funds in Britain's most innovative biotech, medicine and life sciences companies.



from Biotech News
Share:

Alexion Pharmaceuticals, Inc. (ALXN) Given Average Recommendation of "Buy" by Analysts

Alexion Pharmaceuticals, Inc. (ALXN) Given Average Recommendation of "Buy" by Analysts


Shares of Alexion Pharmaceuticals, Inc. have been given a consensus recommendation of "Buy" by the twenty-four ratings firms that are covering the company, Marketbeat Ratings reports. One research analyst has rated the stock with a sell recommendation, three have assigned a hold recommendation and eighteen have issued a buy recommendation on the company.



from Biotech News
Share:

Celsion Co. (CLSN) Expected to Announce Quarterly Sales of $130,000.00

Celsion Co. (CLSN) Expected to Announce Quarterly Sales of $130,000.00


Wall Street analysts expect Celsion Co. to post $130,000.00 in sales for the current fiscal quarter, according to Zacks Investment Research .



from Biotech News
Share:

Doctors drive home a point: Get a flu shot

Doctors drive home a point: Get a flu shot


The Centers for Disease Control and Prevention reported Friday that flu hospitalization rates across the country were the highest ever seen at this point in the season since tracking began in 2005. The most common symptoms of flu are fever, cough and sore throat, according to state health officials.



from Biotech News
Share:

Trinity Biotech (TRIB) Upgraded to Hold by Zacks Investment Research

Trinity Biotech (TRIB) Upgraded to Hold by Zacks Investment Research


According to Zacks, "Trinity Biotech plc, headquartered in Bray, the Republic of Ireland, develops, acquires, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market worldwide. The company provides two haemostasis product lines, Biopool and Amax, comprising test kits and instrumentation used for the detection of blood disorders.



from Biotech News
Share:

Download-Region bei Steam ändern

Download-Region bei Steam ändern


Gelegentlich gestalten sich die Downloads bei Steam ziemlich zähfließend. Meistens ist dafür eine erhöhte Serverauslastung verantwortlich, wenn neue Spiele veröffentlicht werden. Dieses Problem lässt sich in der Regel durch die Auswahl einer anderen Download-Region schnell beheben.

Wenn du auf eine andere Region ausweichen möchtest, dann starte den Steam-Client und melde dich mit deinen Zugangsdaten an.

Anschließend klickst du in der Menüleiste oben links auf Steam | Einstellungen und wählst im Dialogfenster die Option Downloads aus. Im Drop-Down-Menü von Downloadregion wählst aus der Liste eine andere Region aus.

Eine weitere Verbesserung der Downloadgeschwindigkeit kann über die Bandbreite erreicht werden. Unter dem Bereich der Downloadregion lassen sich bei der Option Downloadbandbreite begrenzen verschiedene Geschwindigkeiten einstellen. Optimalerweise wählst du hier den Eintrag Keine Beschränkung aus.

Abschließend musst du nur noch alle vorgenommenen Änderungen mit dem Button OK bestätigen, damit sie aktiviert werden.



Supported by World News Digest
Share:

Newly Launched Cancer.com Provides Much Needed Personalized Support for People Impacted By Cancer

Newly Launched Cancer.com Provides Much Needed Personalized Support for People Impacted By Cancer


Whether you've helped a family member through treatment or are facing a diagnosis yourself, hearing the word "cancer" can make people feel powerless and overwhelmed. For many, the best way to regain control is to be as educated as possible.



from Biotech News
Share:

Teva Pharmaceutical Industries (TEVA) Downgraded by BTIG Research to Sell

Teva Pharmaceutical Industries (TEVA) Downgraded by BTIG Research to Sell


They currently have a $17.00 target price on the stock. BTIG Research's target price would indicate a potential downside of 19.74% from the company's current price.



from Biotech News
Share:

Some Medicaid recipients will be required to work

Some Medicaid recipients will be required to work


INDIANAPOLIS - Indiana will soon require some people receiving Medicaid benefits to work in order to qualify for the health insurance program or to keep their coverage. Alex Azar, the new US Heath and Human Services Secretary, joined Governor Eric Holcomb Friday to make the announcement.



from Biotech News
Share:

Pharmacy News Digest

Архив блога